Evidence map›Paper›PMID 41208907›Full record

ArticleInternational journal of cardiology. Congenital heart disease2025

Long-term outcome after surgical ventricular septal defect closure: Longitudinal follow-up into the fifth decade.

Sahra Ünlütürk, Robert M Kauling, Judith A A E Cuypers, Annemien E van den Bosch, Alexander Hirsch, Chiara Pelosi, Daniel J Bowen, Raluca G Chelu, Ad J J C Bogers, Willem A Helbing and 2 more

Abstract read
In one paragraph

Article in International journal of cardiology. Congenital heart disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sahra ÜnlütürkDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Robert M KaulingDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Judith A A E CuypersDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Annemien E van den BoschDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Alexander HirschDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Chiara PelosiDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Daniel J BowenDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Raluca G CheluDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
Ad J J C BogersDepartment of Cardiothoracic Surgery, Thorax Center, Erasmus MC, Rotterdam, the Netherlands.
Willem A HelbingDepartment of Pediatrics, Division of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Isabella KardysClinical Epidemiology and Innovation Unit, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Jolien W Roos-HesselinkDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To evaluate survival, clinical outcome and quality of life (QoL) of patients up to 49 years after surgical ventricular septal defect (VSD) closure. Methods: Single-center, longitudinal cohort study evaluating consecutive patients with surgical VSD closure between 1968 and 1980 with extensive cardiac and QoL evaluation every decade. Results: Of the original cohort of 174 patients, 39 died (22 %), 8 were lost to follow-up and 38 had not participated previously. Survival rate at 49 years follow-up was 77 % and 86 % when excluding early postoperative mortality. Of the 89 eligible survivors, 76 (85 %) were evaluated (59 % male, median age 49 [44-54] years) with a median follow-up of 44 (range 40-49) years after surgery. Event-free survival at 49 years was 50 %, with symptomatic arrhythmias (10 %), pacemaker implantation (8 %) and VSD-related interventions (3 %) being common complications. At last follow-up, 58 % had left atrial dilation, 25 % had aortic regurgitation and 5 patients (7 %) had a residual VSD. Early postoperative arrhythmias predicted mortality. Both left ventricular (LV) and right ventricular ejection fraction remained stable, with only 1 % having an LV ejection fraction below 45 % at last follow-up. Exercise capacity and VO Conclusion: Half of the patients with surgical VSD closure had an event-free survival at 49 years. Pacemaker implantation was often needed. Early postoperative arrhythmias predicted mortality. QoL was good and remained stable over time.

Indexed as

Cardiac surgeryLong-term outcomeQuality of lifeSurgical VSD closureVentricular septal defect

Identifiers

PMID41208907
PMCPMC12594936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.